Viral hepatitis, a group of infectious diseases, affects millions of people worldwide. The World Health Organization (WHO) estimates 325 million people worldwide are living with chronic hepatitis B or chronic hepatitis C. Deaths due to viral hepatitis reached 1.34 million in 2015, comparable to the number of deaths caused by tuberculosis and HIV. Yet, effective measures such as educational programs for people who inject drugs and ensuring infants born to hepatitis B infected mothers are vaccinated against hepatitis B would dramatically reduce hepatitis B and C infections worldwide.
Join the Centers for Disease Control and Prevention (CDC) for a live webcast of the next Public Health Grand Rounds. This session of Public Health Grand Rounds will discuss how new therapies and technologies can be used to eliminate hepatitis B and C. Learn how multiple approaches and working with health partners can help eliminate these diseases. Find out about the promising work that Australia, the state of New Mexico, and the city of San Francisco are doing.
For non-CDC staff interested in viewing the session: A live external webcast will be available via the streaming platforms on our website. For individuals who are unable to view the session during the scheduled time, a video of the session will be posted to CDC’s On Demand page 3-4 days after the presentation.